Synthesis, Structure-Affinity Relationships, and Biological Activities of Ligands Binding to Retinoic Acid Receptor Subtypes

Journal of Medicinal Chemistry

Volumn 38, Issue 26, 1995, Pages 4993-5006

  Charpentier, Bruno ^a   Bernardon, Jean Michel ^a   Eustache, Jacques ^b   Millois, Corinne ^a   Martin, Bernard ^a   Michel, Serge ^a   Shroot, Braham ^a  

^a Galderma R and D   (France)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

4 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 ANTHRYL)BENZOIC ACID; 6 [3 (1 ADAMANTYL) 4 HYDROXYPHENYL] 2 NAPHTHOIC ACID; ADAPALENE; RECEPTOR SUBTYPE; RETINOIC ACID RECEPTOR; UNCLASSIFIED DRUG;

ACNE; ARTICLE; BINDING AFFINITY; CELL DIFFERENTIATION; CELL PROLIFERATION; GENETIC REGULATION; KERATINIZATION; LIGAND BINDING; NONHUMAN; PROTEIN DOMAIN; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; TRANSCRIPTION REGULATION;

EID: 0029562846     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00026a006     Document Type: Article

References (44)

1. Gudas, L. J.; Spom, M. B.; Roberts, A. B. Cellular biology and biology and biochemistry of the retinoids. In The Retinoids, Biology, Chemistry and Medicine; Spom, M. B., Roberts, A. B., Goodman, D. S., Eds.; Raven Press: New York, 1994; pp 443-520.
2. Pawson, B. A.; Ehmann, C. W.; Itri, L. M.; Sherman, M. I. Retinoids at the threshold: Their biological significance and therapeutic potential. J. Med. Chem. 1982, 25, 1269-1277.
3. Boyd, A. S. An Overview of Retinoids. Am. J. Med. 1989, 86, 568-574.
4. Hong, W. K.; Itri, L. M. Retinoids and human cancer. In The Retinoids, Biology, Chemistry and Medicine; Spom, M. B., Roberts, A. B., Goodman, D. S., Eds.; Raven Press: New York, 1994; pp 597-630.
5. Chomienne, C.; Ballerini, P.; Balitrand, N.; Amor, M.; Bernard, J. F.; Boivin, P.; Daniel, M. T.; Berger, R.; Castaigne, S.; Degos, L. Retinoic acid therapy for promyelocytic leukaemia. Lancet 1989, 2, 746-747.
6. Mangelsdorf, D. J.; Umesono, K.; Evans, R. M. The retinoid receptors. In The Retinoids, Biology, Chemistry and Medicine; Sporn, M. B., Roberts, A. B., Goodman, D. S., Eds.; Raven Press: New York, 1994; pp 319-349.
7. Amstrong, R. B.; Ashenfelter, K. O.; Eckhoff, C.; Levin, A. A.; Shapiro, S. S. General and reproductive toxicology of retinoids. In The Retinoids, Biology, Chemistry and Medicine; Sporn, M. B., Roberts, A. B., Goodman, D. S., Eds.; Raven Press: New York, 1994; pp 545-572.
8. Zelent, A.; Krust, A.; Petkovich, M.; Kastner, P.; Chambon, P. Cloning of murine a and f retinoic acid receptors and a novel receptor predominantly expressed in skin. Nature 1989, 339, 714-717.
9. Fisher, G. J.; Talwar, H. S.; Xiao, J. H.; Datta, S. C.; Reddy, A. P.; Gaub, M. P.; Rochette-Egly, C.; Chambon, P.; Voorhees, J. J. Immunological identification and functional quantitation of retinoic acid and retinoid X receptor proteins in human skin. J. Biol. Chem. 1994, 269, 20629-20635.
10. Hashimoto, Y.; Kagechika, H.; Shudo, K. Expression of retinoic acid receptor genes and the ligand-binding selectivity of retinoic acid receptors (RAR’s). Biochem. Biophys. Res. Commun. 1990, 166, 1300-1307.
11. Delescluse, C.; Cavey, M. T.; Martin, B.; Bernard, B. A.; Reichert, U.; Maignan, J.; Darmon, M.; Shroot, B. Selective high affinity retinoic acid receptor a or /?-y ligands. Mol. Pharmacol. 1991, 40, 556-562.
12. Apfel, C.; Bauer, F.; Crettaz, M.; Forni, L.; Kamber, M.; Kaufmann, F.; LeMotte P.; Pirson, W.; Klaus, M. A retinoic acid receptor alpha antagonist selectively counteracts retinoic acid effects. Proc. Natl. Acad. Sci. U. S. A. 1992, 89, 7129-7133.
13. Martin, B.; Bemardon, J. M.; Cavey, M. T.; Bernard, B.; Carlavan, I.; Charpentier, B.; Pilgrim, W. R.; Shroot, B.; Reichert, U. Selective synthetic ligands for human nuclear retinoic acid receptors. Skin Pharmacol. 1992, 5, 57-65.
14. Bernard, B. A.; Bemardon, J. M.; Delescluse, C.; Martin, B.; Lenoir, M. C., Maignan, J.; Charpentier, B.; Pilgrim, W. R.; Reichert, U.; Shroot, B. Identification of synthetic retinoids with selectivity for human nuclear retinoic acid receptor γ. Biochem. Biophys. Res. Commun. 1992, 186, 977-983.
15. Schadendorf, D.; Worm, M.; Jurgovsky, K.; Dippel, E.; Michel, S.; Charpentier, B.; Bemardon, J. M.; Reichert, U.; Czametzki, B. M. Retinoic acid receptor-y-selective retinoids exert antiproliferative effects on human melanoma cell growth in vitro. Int. J. Oncol. 1994, 5, 1325-1331.
16. Lehmann, J. M.; Jong, L.; Fanjul, A.; Cameron, J. F.; Lu, X. P.; Haefner, P.; Dawson, M. I.; Pfahl, M. Retinoids selective for retinoid X receptor response pathway. Science 1992, 258, 1944-1946.
17. Chandraratna, R. World Pat. Appl. 17796, February 11, 1993.
18. Boehm, M. F.; Zhang, L.; Badea, B. A.; White, S. K.; Mais, D. E.; Berger, E.; Suto, C. M.; Goldman, M. E.; Heyman, R. A. Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids. J. Med. Chem. 1994, 37, 2930-2941.
19. Negishi, E. I. Palladium- or nickel-catalyzed cross-coupling. A new selective method for carbon-carbon bond formation. Acc. Chem. Res. 1982, 15, 340-348.
20. Duval, D.; Predine, J.; Charpentier, B.; Emiliozzi, R. Synthesis of 7a- and /3-carboxymethyl derivatives of cortisol, corticosterone, deoxycorticosterone and cortisone. Immunogenic properties of cortisol, corticosterone and deoxycorticosterone derivatives. J. Steroid. Biochem. 1985, 22, 67-78.
21. Cacchi, S.; Ciattini, P. G.; Morera, E.; Ortar, G. Palladium-catalyzed carbonylation of aryl triflates. Synthesis of arenecar-boxylic acid derivatives from phenols. Tetrahedron Lett. 1986, 27, 3931-3934.
22. Stille, J. K. The palladium-catalyzed cross-coupling reactions of organotin reagents with organic electrophiles. Angew. Chem., Int. Ed. Engl. 1986, 25, 508-524.
23. Knights, E. F.; Brown, H. C. 9-Borabicyclo[3. 3. 1]nonane as a convenient selective hydroborating agent. J. Am. Chem. Soc. 1968, 90, 5281-5283.
24. VanRheenen, V.; Kelly, R. C.; Cha, D. Y. An improved catalytic OSO4 oxidation of olefins to cis-1, 2-glycols using tertiary amine oxides as the oxidant. Tetrahedron Lett. 1976, 23, 1973-1976.
25. Heck, R. F. Palladium reagent in organic synthesis. In Best Synthetic Methods’, Katritzky, A. R., Meth-Cohn, O., Rees, C. W., Eds.; Academic Press: New York, 1985.
26. Baker, R.; Sims, R. J. A convenient modification of the Wadsworth-Emmons method of olefin formation using a crown ether. Synthesis 1981, 117-118.
27. Kelly, T. R.; Dali, H. M.; Tsang, W. G. Lithium thiomethoxide: a convenient mercaptide reagent. Tetrahedron Lett. 1977, 3859-3860.
28. Loeliger, P.; Bollag, W.; Mayer, H. Arotinoids, a new class of highly active retinoids. Eur. J. Med. Chem. Chim. Ther. 1980, 15, 9-15.
29. Shroot, B.; Eustache, J.; Watts, O.; Bemardon, J. M.; Nedoncelle, P. Eur. Pat. Appl. 210929, July 25, 1985.
30. Dawson, M. I.; Hobbs, P. D.; Derdzinski, K. A.; Chao, W. R.; Frenking, G.; Loew, G. H.; Jetten, A. M.; Napoli, J. L.; Williams, J. B.; Sani, B. P.; Wille, J. J., Jr.; Schiff, L. J. Effect of structural modifications in the C7-C11 region of the retinoid skeleton on biological activity in a series of aromatic retinoids. J. Med. Chem. 1989, 32, 1504-1517.
31. Shroot, B.; Darmon, Y. M.; Nedoncelle, P.; Martin, C. Eur. Pat. Appl. 359 621, September 1, 1988.
32. Cavey, M. T.; Martin, B.; Carlavan, I.; Shroot, B. In vitro binding of retinoids to the nuclear retinoic acid receptor a. Anal. Biochem. 1990, 186, 1923.
33. 3H3]4-(5′, 6′, 7′, 8′-tetrahydro-5′, 5′, 8′, 8′-tetramethyl-2′-anthracenyl) benzoic acid for binding studies of retinoic acid receptor. J. Labelled Compd. Radiopharm. 1993, 33, 633-637.
34. Dawson, M. I.; Chan, R. L.; Derdzinski, K.; Hobbs, P. D.; Chao, W. R.; Schiff, L. J. Synthesis and pharmacological activity of 6-[ (E)-2-(2, 6, 6-trimethyl-1-cyclohexen-1-yl) ethen-1-yl]- and 6-(1, 2, 3, 4-Tetrahydro-1, l, 4, 4-tetramethyl-6-naphthyl)-2-naphthalene-carboxylic acids. J. Med. Chem. 1983, 26, 1653-1656.
35. Schiff, L. J.; Okamura, W. H.; Dawson, M. I.; Hobbs, P. D. Structure-biological activity relationships of new synthetic retinoids on epithelial differentiation of cultured hamster trachea. In Chemistry and Biology of Synthetic Retinoids; Dawson, M. I., Okamura, W. H., Eds.; CRC Press, Inc.: Boca Raton, FL, 1990; pp 308-363.
36. Strickland, S.; Mahdavi, V. The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell 1978, 15, 393-403.
37. Darmon, M.; Rocher, M.; Cavey, M. T.; Martin, B.; Rabilloud, T.; Delescluse, C.; Shroot, B. Biological activity of retinoids correlates with affinity for nuclear receptors, but not for cytosolic binding protein. Skin Pharmacol. 1988, 1, 161-175.
38. Hu, L.; Gudas, L. J. Cyclic AMP analogs and retinoic acid influence the expression of retinoic acid receptor alpha, beta and gamma mRNAs in F9 teratocarcinoma cells. Mol. Cell. Biol. 1990, 10, 391-396.
39. Boylan, J. F.; Lufkin, T.; Achkar, C. C.; Taneja, R.; Chambon, P.; Gudas, L. J. Targeted disruption of retinoic acid receptor a (RARa) and RAR y results in receptor-specific alterations in retinoic acid-mediated differentiation and retinoic acid metabolism. Mol. Cell. Biol. 1995, 15, 843-851.
40. Zhang, X. K.; Pfahl, M. Hetero- and homodimeric receptors in thyroid hormone and vitamin A action. Receptor 1993, 3, 183-191.
41. Bemerd, F.; Ortonne, J. P.; Bouclier, M.; Chatelus, A.; Hensby, C. The rhino mouse model: The effects of topically applied all-trans retinoic acid and CD 271 on the fine structure of the epidermis and utricle wall of pseudocomedones. Arch. Dermatol. Res. 1991, 283, 100-107.
42. Griffiths, C. E. M.; Elder, J. T.; Bernard, B. A.; Rossio, P.; Cromie, A. M.; Finkel, L. J.; Shroot, B.; Voorhees, J. J. Comparison of CD 271 (adapalene) and all-trans retinoic acid in human skin: dissociation of epidermal effects and CRABP-II mRNA expression. J. Invest. Dermatol. 1993, 101, 325-328.
43. Verschoore, M.; Langner, A.; Wolska, H.; Jablonska, S.; Czernielewski, J.; Schaefer, H. Efficacy and safety of CD 271 alcoholic gels in the topical treatment of acne vulgaris. Br. J. Dermatol. 1991, 124, 368-371.
44. Janssen, B.; Wuest, H. H. Eur. Pat. 386452, February 10, 1989.